The Value of Convolutional Neural Network-Based Magnetic Resonance Imaging Image Segmentation Algorithm to Guide Targeted Controlled Release of Doxorubicin Nanopreparation

<div>MRI images of a 55-year-old male patient with liver cancer. (a–d) T1, T2, T1W1, and T2W2 phase maps processed by traditional CNN MRI image segmentation algorithm; (e–h) T1, T2, T1W1, and T2W2 phase maps processed by the upgraded 3D CNN-based MRI image segmentation algorithm.</div>

Contrast Media & Molecular Imaging

fig3

Figure 3

Figure 3: The Value of Convolutional Neural Network-Based Magnetic Resonance Imaging Image Segmentation Algorithm to Guide Targeted Controlled Release of Doxorubicin Nanopreparation 

Figure 3 | The Value of Convolutional Neural Network-Based Magnetic Resonance Imaging Image Segmentation Algorithm to Guide Targeted Controlled Release of Doxorubicin Nanopreparation 